• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Constitutes
© 2025 Longbridge|Disclaimer

Event Tracking

Dec16
Cambricon Successfully Adapts to SENSETime's Self-Research Seko Series
11:20
Dec15
Rongchang Biotechnology Plans to Repurchase A-shares for Up to 40 Million Yuan
16:32
Hengrui Medicine Receives Clinical Trial Approvals for Four Products
00:22
Dec14
Junshi Biosciences' EGFR/HER3 Bispecific Antibody-Drug Conjugate JS212 Clinical Trial Approved by FDA
07:49
Dec13
2025 National Medical Insurance Drug Directory Update, Hengrui and Eli Lilly are Major Winners
03:47
Dec12
Hengrui Medicine's Subsidiary Receives Clinical Trial Approval Notice for RSS0343 Tablets from NMPA
11:57